Ana Charrua Selected Research

Ana Charrua Research Topics

Disease

12	Pain (Aches) 01/2024 - 11/2003
6	Inflammation (Inflammations) 10/2023 - 07/2004
5	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2024 - 06/2015
5	Cystitis 01/2020 - 12/2004
3	Lower Urinary Tract Symptoms 02/2024 - 01/2019
3	Visceral Pain 01/2024 - 03/2015
2	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 02/2024 - 01/2022
2	Chronic Pain 01/2024 - 10/2019
2	Pelvic Pain 11/2023 - 01/2021
2	Underactive Urinary Bladder 01/2022 - 09/2019
1	Weight Loss (Weight Reduction) 02/2024
1	Endometriosis 11/2023
1	Overactive Urinary Bladder (Overactive Bladder) 04/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Ischemia 01/2019
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2018
1	Metrorrhagia (Spotting) 06/2015
1	Hypersensitivity (Allergy) 10/2012
1	Fatigue 01/2012
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2012
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2008
1	Bone Neoplasms (Bone Cancer) 12/2008
1	Hyperalgesia 12/2004
1	Abnormal Reflex (Hyperreflexia) 12/2004
1	Hemorrhagic Cystitis 12/2004
1	Body Weight (Weight, Body) 07/2004
1	Hyperinsulinism (Hyperinsulinemia) 11/2003

Drug/Important Bio-Agent (IBA)

4	LipopolysaccharidesIBA 01/2020 - 04/2007
4	TRPV Cation ChannelsIBA 07/2019 - 11/2003
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2024 - 06/2015
3	Nerve Growth Factor (NGF)IBA 10/2019 - 10/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2008 - 07/2004
2	Adenosine Triphosphate (ATP)IBA 02/2024 - 01/2022
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2024 - 08/2017
2	anandamide (arachidonylethanolamide)IBA 01/2020 - 12/2004
2	Type A Botulinum Toxins (Botox)FDA Link 01/2018 - 01/2012
2	resiniferatoxinIBA 12/2008 - 07/2004
1	LipidsIBA 02/2024
1	Sodium-Glucose Transport ProteinsIBA 02/2024
1	KetonesIBA 02/2024
1	Ketone BodiesIBA 02/2024
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 11/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2023
1	silodosin FDA Link 09/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022
1	EndocannabinoidsIBA 01/2020
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2020
1	URB937IBA 01/2020
1	Ion Channels (Ion Channel)IBA 01/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 10/2019
1	TropomyosinIBA 10/2019
1	Serotonin (5 Hydroxytryptamine)IBA 09/2019
1	Glucose (Dextrose)FDA LinkGeneric 07/2019
1	cyclopropapyrroloindoleIBA 01/2019
1	CatecholaminesIBA 06/2015
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 06/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2015
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 06/2015
1	N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA 03/2015
1	RN 1734IBA 03/2015
1	Urethane (Ethyl Carbamate)IBA 01/2012
1	Messenger RNA (mRNA)IBA 10/2008
1	capsazepineIBA 12/2004
1	Acrolein (Aqualin)IBA 07/2004
1	salicylhydroxamic acid (SHAM)IBA 07/2004
1	Insulin ReceptorIBA 11/2003
1	Insulin (Novolin)FDA Link 11/2003
1	Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)IBA 11/2003

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2018
1	Glycemic Control 02/2024
1	Ketogenic Diet 02/2024
1	Radiotherapy 01/2019
1	Injections 01/2018
1	Analgesia 12/2008
1	Spinal Injections 12/2008
1	Urinary Catheters 07/2004